Thermo Fisher Scientific Inc
corporate.thermofisher.comThermo Fisher Scientific Inc. (NYSE: TMO) is a life sciences and laboratory technology company that supplies instruments, reagents, consumables, software, and services to researchers, diagnosticians, and manufacturers worldwide. Revenue is generated across four reported segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services, combining product sales with recurring consumable and service streams. Customers span pharmaceutical and biotech companies, hospitals, clinical diagnostic labs, universities, research institutions, government agencies, and environmental and industrial settings. The business benefits from high switching costs embedded in installed instrument bases, where consumables and service contracts follow the hardware sale. The company is headquartered in the United States and describes itself as a global operation. Marc N. Casper has served as CEO. The 10-K filed 2026-02-26 (accession 000009774526000018) covers FY2025 operations.
Products & Services
Instruments, reagents, consumables, software, and services across life sciences, analytical instrumentation, specialty diagnostics, and laboratory products. Contract development and manufacturing services for biopharma customers are included in the Biopharma Services segment.
Revenue Model
Revenue comes from product sales (instruments, reagents, consumables) and services (contract manufacturing, biopharma services, instrument service contracts). Consumables and services attached to installed instrument bases create recurring revenue after initial hardware placement.
Customers & Markets
Pharmaceutical and biotech companies, hospitals, clinical diagnostic labs, universities, research institutions, government agencies, and environmental and industrial settings.
Geographic Exposure
Global operations. Specific revenue breakdown by geography not supported by the provided filing excerpts.
Financial Snapshot
Loading...
